Cinctive Capital Management LP View Ray, Inc. Transaction History

Cinctive Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.65 - $4.82 $2.79 Million - $3.69 Million	764,555 New	764,555 $3.43 Million
Q2 2022 Aug 15, 2022	SELL	$2.42 - $4.05 $1.15 Million - $1.92 Million	-473,432 Reduced 64.47%	260,884 $691,000
Q1 2022 May 16, 2022	BUY	$3.45 - $5.83 $136,613 - $230,856	39,598 Added 5.7%	734,316 $2.88 Million
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $2.35 Million - $3.64 Million	479,718 Added 223.12%	694,718 $3.83 Million
Q3 2021 Nov 15, 2021	BUY	$5.18 - $7.41 $518,000 - $741,000	100,000 Added 86.96%	215,000 $1.55 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $6.75 $453,100 - $776,250	115,000 New	115,000 $759,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.